Brain Pathology

Papers
(The median citation count of Brain Pathology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading349
cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors158
Neuropathologic features of four autopsied COVID‐19 patients140
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis73
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐1970
COVID‐19‐related neuropathology and microglial activation in elderly with and without dementia70
Pathology, diagnostics, and classification of medulloblastoma66
The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors66
Loss of capillary pericytes and the blood–brain barrier in white matter in poststroke and vascular dementias and Alzheimer’s disease58
Brain ischemic injury in COVID‐19‐infected patients: a series of 10 post‐mortem cases54
The microbiota–microglia axis in central nervous system disorders50
Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update47
Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions45
The role of interferons type I, II and III in myositis: A review43
Intracranial mesenchymal tumor with FET‐CREB fusion—A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma‐like neoplasms40
Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy37
Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia36
Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer's disease neuropathology35
MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)35
IL‐1β/IL‐1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha‐Synuclein pathology in the olfactory bulb, substantia nigra and striatum35
Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease35
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease31
Interaction of microglia with infiltrating immune cells in the different phases of stroke30
Genomic mechanisms in Alzheimer's disease29
The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature28
TERT promoter mutations in primary and secondary WHO grade III meningioma27
Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it?27
Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond27
Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome27
Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives26
MRI and muscle imaging for idiopathic inflammatory myopathies25
Prognostic impact of genetic alterations and methylation classes in meningioma25
Glycocalyx is critical for blood‐brain barrier integrity by suppressing caveolin1‐dependent endothelial transcytosis following ischemic stroke25
Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change and microvascular pathologies in community‐dwelling older persons24
Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease24
Postmortem neuropathology in COVID‐1924
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP23
Increased expression of miR142 and miR155 in glial and immune cells after traumatic brain injury may contribute to neuroinflammation via astrocyte activation23
Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex22
Infective myositis22
Role of mTOR‐regulated autophagy in spine pruning defects and memory impairments induced by binge‐like ethanol treatment in adolescent mice21
Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia21
Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer’s disease and other tauopathies20
A Zika virus primary isolate induces neuroinflammation, compromises the blood‐brain barrier and upregulates CXCL12 in adult macaques19
Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias19
Denser brain capillary network with preserved pericytes in Alzheimer's disease19
The use and limitations of single‐cell mass cytometry for studying human microglia function18
Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells18
Distinct circular RNA expression profiles in pediatric ependymomas17
Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease17
Hypothesis review: Alzheimer's overture guidelines17
Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications17
Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains17
TREM2‐induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology17
PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation17
Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma16
Endothelium‐targeted overexpression of Krüppel‐like factor 11 protects the blood‐brain barrier function after ischemic brain injury16
Extralysosomal cathepsin B in central nervous system: Mechanisms and therapeutic implications15
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor‐initiating cells15
Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration15
Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing15
Inflammatory features in sporadic late‐onset nemaline myopathy are independent from monoclonal gammopathy15
Diverse changes in microglia morphology and axonal pathology during the course of 1 year after mild traumatic brain injury in pigs15
A deep learning‐based model for prediction of hemorrhagic transformation after stroke14
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans14
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup14
Integrated genotype–phenotype analysis of long‐term epilepsy‐associated ganglioglioma14
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tiss14
Multiple system atrophy variant with severe hippocampal pathology14
Reconstituting neurovascular unit with primary neural stem cells and brain microvascular endothelial cells in three‐dimensional matrix14
Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid13
Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non‐motor dysfunction13
Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer’s disease and the role of glial cells13
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis13
Molecular diagnostics in drug‐resistant focal epilepsy define new disease entities13
Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases13
Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis13
Congenital tumors of the central nervous system: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics13
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases12
Differential diagnosis of vacuolar myopathies in the NGS era12
Mini‐symposium in medulloblastoma genomics in the modern molecular era12
Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer’s disease12
Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18F‐FDG PET‐CT values12
Effect of olfactory bulb pathology on olfactory function in normal aging12
Neonatal apneic phenotype in a murine congenital central hypoventilation syndrome model is induced through non‐cell autonomous developmental mechanisms12
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome11
Focal cortical dysplasia type 111
A novel temporal‐predominant neuro‐astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS‐TDP11
Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders11
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies11
Neuropathology of COVID‐19: where are the neuropathologists?11
Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG35‐55‐induced EAE through ERK and Akt signalling11
Axonal injury following mild traumatic brain injury is exacerbated by repetitive insult and is linked to the delayed attenuation of NeuN expression without concomitant neuronal death in the mouse11
Region‐specific preservation of Purkinje cell morphology and motor behavior in the ATXN1[82Q] mouse model of spinocerebellar ataxia 111
The molecular etiology of Alzheimer’s disease11
NanoString technology distinguishes anti‐TIF‐1γ+ from anti‐Mi‐2+ dermatomyositis patients11
High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy11
Considerations for integrative multi‐omic approaches to explore Alzheimer's disease mechanisms11
Expanding the spectrum of EWSR1‐PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination11
Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress10
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies10
Glial activation in prion diseases is selectively triggered by neuronal PrPSc10
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease10
Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology10
Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas10
Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease10
Evaluating the performance of large language models: ChatGPT and Google Bard in generating differential diagnoses in clinicopathological conferences of neurodegenerative disorders10
Molecular neuropathology of brain‐invasive meningiomas10
Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer’s disease10
Use of advanced neuroimaging and artificial intelligence in meningiomas10
Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era9
Stimulation of retrotrapezoid nucleus Phox2b‐expressing neurons rescues breathing dysfunction in an experimental Parkinson’s disease rat model9
Motor neuron involvement expands the neuropathological phenotype of late‐onset ataxia in RFC1 mutation (CANVAS)9
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis9
Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants9
Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease9
Does etiology really matter for epilepsy surgery outcome?9
Targeting the interaction of GABAB receptors with CaMKII with an interfering peptide restores receptor expression after cerebral ischemia and inhibits progressive neuronal death in mouse br9
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study9
Overexpression of the ubiquitin‐editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation9
Medullary tyrosine hydroxylase catecholaminergic neuronal populations in sudden unexpected death in epilepsy9
Epithelioid glioblastoma with microglia features: potential for novel therapy9
Molecular landscape of IDH‐wild type, pTERT‐wild type adult glioblastomas8
Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer’s and small vessel disease pathologies8
Applying gene‐editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer’s disease8
Brain‐specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injury8
Epigenome‐wide association studies in Alzheimer’s disease; achievements and challenges8
Automated and unbiased discrimination of ALS from control tissue at single cell resolution8
Deficiency of Tet3 in nucleus accumbens enhances fear generalization and anxiety‐like behaviors in mice7
Application of single cell genomics to focal epilepsies: A call to action7
Variable histopathology features of neuronal dyslamination in the cerebral neocortex adjacent to epilepsy‐associated vascular malformations suggest complex pathogenesis of focal cortical dysplasia ILA7
lncRNA MEG3 restrained the M1 polarization of microglia in acute spinal cord injury through the HuR/A20/NF‐κB axis7
The fate of interneurons, GABAA receptor sub‐types and perineuronal nets in Alzheimer's disease7
Embryonal and non‐meningothelial mesenchymal tumors of the central nervous system – Advances in diagnosis and prognostication7
Independent distribution between tauopathy secondary to subacute sclerotic panencephalitis and measles virus: An immunohistochemical analysis in autopsy cases including cases treated with aggressive a7
ZFTA‐YAP1 fusion‐positive ependymoma can occur in the spinal cord: Letter to the editor7
Muscle pathology of antisynthetase syndrome according to antibody subtypes7
Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology7
IDH‐mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature7
Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma7
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits7
Distinct and dementia‐related synaptopathy in the hippocampus after military blast exposures6
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis6
Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathy6
Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low‐grade haemolysis of fragile macrocytic red blood cells6
Serotonin transporter in the temporal lobe, hippocampus and amygdala in SUDEP6
CHCHD2 p.Thr61Ile knock‐in mice exhibit motor defects and neuropathological features of Parkinson's disease6
Progression of phosphorylated α‐synuclein in Macaca fuscata6
Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology5
Differential perivascular microglial activation in the deep white matter in vascular dementia developed post‐stroke5
Reduction in miR‐219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease5
Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination5
Detection of endophenotypes associated with neuropsychiatric deficiencies in a mouse model of tuberous sclerosis complex using diffusion tensor imaging5
The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status5
A new amplicon‐based gene panel for next generation sequencing characterization of meningiomas5
Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus‐induced demyelination5
Myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant, arising in midbrain tectum with multifocal CSF dissemination5
Antenatal low‐intensity pulsed ultrasound reduces neurobehavioral deficits and brain injury following dexamethasone‐induced intrauterine growth restriction5
The neurovasculature as a target in temporal lobe epilepsy5
No evidence of aberrant amyloid β and phosphorylated tau expression in herpes simplex virus‐infected neurons of the trigeminal ganglia and brain5
Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic later5
Application of deep learning to understand resilience to Alzheimer's disease pathology5
An early proinflammatory transcriptional response to tau pathology is age‐specific and foreshadows reduced tau burden5
Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study5
Microvessel stenosis, enlarged perivascular spaces, and fibrinogen deposition are associated with ischemic periventricular white matter hyperintensities5
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent5
TDP‐43 and tau concurrence in the entorhinal subfields in primary age‐related tauopathy and preclinical Alzheimer's disease5
Genomic profiling and prognostic factors of H3 K27M‐mutant spinal cord diffuse glioma4
Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors4
Brachial plexus lipomatosis with perineurial pseudoonion bulb formation: Result of a mosaic PIK3CA mutation in the para‐axial mesoderm state4
Role of VAPB and vesicular profiles in α‐synuclein aggregates in multiple system atrophy4
Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD4
LAMP‐2A ablation in hippocampal CA1 astrocytes confers cerebroprotection and ameliorates neuronal injury after global brain ischemia4
Double‐edged effects of tamoxifen‐in‐oil‐gavage on an infectious murine model for multiple sclerosis4
Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation4
Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study4
Histamine in murine narcolepsy: What do genetic and immune models tell us?4
Aβ plaques do not protect against HSV‐1 infection in a mouse model of familial Alzheimer's disease, and HSV‐1 does not induce Aβ pathology in a model of late onset Alzheimer's di4
Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 234
The influence of HLA‐DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter4
Information theory approaches to improve glioma diagnostic workflows in surgical neuropathology4
Primary age‐related tauopathy (PART) in the general autopsy setting: Not just a disease of the elderly4
Innate immune activation without immune cell infiltration in brains of murine models of Aicardi‐Goutières Syndrome3
Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant3
Fra‐1 induces apoptosis and neuroinflammation by targeting S100A8 to modulate TLR4 pathways in spinal cord ischemia/reperfusion injury3
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease3
Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis3
Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington’s chorea3
Pathology explains various mechanisms of auto‐immune inflammatory peripheral neuropathies3
3
AtypicalTDP‐43 protein expression in anALSpedigree carrying a p.Y374Xtruncation mutation inTARDBP3
Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy3
Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions3
A 2‐year‐old girl with posterior fossa mass3
Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult3
Exploiting nanopore sequencing for characterization and grading of IDH‐mutant gliomas3
Studying the imaging features and infarction mechanism of vertebrobasilar dolichoectasia with high‐resolution magnetic resonance imaging3
Temporal lobe myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant with DNA methylation confirmation2
Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice2
The myeloid side of the CNS2
Present and future avenues of cell‐based therapy for brain injury: The enteric nervous system as a potential cell source2
Monomeric C‐reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction2
Developmental delay and progressive seizures in 2‐month‐old child with diffuse MRI abnormalities2
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain2
Attenuation of Piwil2 induced by hypoxic postconditioning prevents cerebral ischemic injury by inhibiting CREB2 promoter methylation2
Report two adult cases of high‐grade neuroepithelial neoplasm harbouring EP300::BCOR fusions with comprehensive molecular detection2
Cortical iron accumulation in MAPT‐ and C9orf 72‐associated frontotemporal lobar degeneration2
Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases2
Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein2
The WHO classification of tumors of the central nervous system‐finally here, and welcome!2
Distinct Aβ pathology in the olfactory bulb and olfactory deficits in a mouse model of Aβ and α‐syn co‐pathology2
Inflammatory and oxidative stress markers in intracerebral hemorrhage: Relevance as prognostic markers for quantification of the edema volume2
Targeting autotaxin impacts disease advance in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis2
Hispano‐American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disorders2
Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke2
Loss of fidelity in scanned digital images compared to glass slides of brain tumors resected using cavitron ultrasonic surgical aspirator2
Severe histomorphological alterations in post‐mortem olfactory glomeruli in Alzheimer’s disease2
An H3F3A K27M‐mutation in a sonic hedgehog medulloblastoma2
Leigh syndrome is the main clinical characteristic of PTCD3 deficiency2
0.1051139831543